Combination of Radiation Therapy and Anti-PD-1 Antibody SHR-1210 in Treating Patients With Esophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Esophageal Squamous Cell Carcinoma
Related studies linked through entity extraction aliases.
Anti-HER2 Therapy in Patients of HER2 Positive Metastatic Carcinoma of Digestive System
- Status
- UNKNOWN
- Phase
- PHASE2
HIV and Other Risk Factors for Esophageal Squamous Cell Carcinoma in Malawi
- Status
- COMPLETED
- Phase
- N/A
Study of IBI308 With Advanced/Metastatic Esophageal Squamous Cell Carcinoma After Failure of First-line Treatment
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of TPF Induction Chemotherapy for Borderline-resectable Esophageal Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Apatinib for Esophageal Squamous Cell Cancer After the Failure of Standard Treatment
- Status
- COMPLETED
- Phase
- PHASE2
Study of Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Study of Extensive Clinical Target Volumes in Postoperative Radiotherapy Concurrent With Chemotherapy for Esophageal Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
The Study to Evaluate Toripalimab (JS001) in Patients With Advanced GC, ESCC, NPC, HNSCC
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
S-1 IMRT Versus S-1 and Cisplatin Concurrent IMRT in Inoperable Esophageal Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Swallowable Sponge Cell Sampling Device and Next Generation Sequencing in Detecting Esophageal Cancer in Patients With Low or High Grade Dysplasia, Barrett Esophagus, or Gastroesophageal Reflux Disease
- Status
- COMPLETED
- Phase
- NA
Preoperative Chemoradiotherapy and MK-3475 for Esophageal Squamous Cell Carcinoma (ACTS-29)
- Status
- COMPLETED
- Phase
- PHASE2
Cisplatin Combined With S-1 or Paclitaxel as First-line Treatment for Metastatic Esophageal Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE3
Endostar Combined With NVB and DDP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas
- Status
- UNKNOWN
- Phase
- PHASE2
Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study of Anlotinib in Patients With Esophageal Squamous Cell Carcinoma (ALTER1102)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Comparing Huachansu Plus Thoracic RT Versus RT Alone For ESCC
- Status
- COMPLETED
- Phase
- PHASE2
Apatinib and Irinotecan Combination Treatment in Esophageal Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Radiotherapy Combined With S-1/DDP for Elderly Esophageal Squamous Cell Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
Paclitaxel or S1 Plus Cisplatin in Concurrent Chemoradiotherapy for Squamous Cell Carcinoma of Esophagus
- Status
- UNKNOWN
- Phase
- PHASE2